News Join our mailing list to receive our quarterly email newsletter with news, updates and events in bowel management. SUBSCRIBE AllCancerCoeliac DiseaseConstipationIncontinenceIBSInflammatory Bowel DiseasePaediatricsCrohn's DiseaseEnterome & Nestlé collaborate on immunotherapies for inflammatory bowel disease and food allergiesJuly 18, 2022Ustekinumab and adalimumab showed high rates of remission for Crohn’s in SEAVUE studyJune 21, 2022NHS Scotland approve JYSELECA®▼ (filgotinib) for Ulcerative Colitis (UC)May 9, 2022MHRA grants early access to AbbVie’s treatment for Crohn’s DiseaseApril 21, 2022Implantica announces launch of RefluxStop™ in UKMarch 29, 2022Guts UK Irritable Bowel Syndrome SurveyMarch 10, 2022New therapeutic options for childhood inflammatory bowel diseaseFebruary 24, 2022REMSWITCH study showed reduced relapse risk in IBD when switching to SC treatment.February 21, 2022Prostate cancer diagnostic device recommended by NICEFebruary 15, 2022MHRA approves Jyseleca®▼ as new treatment for ulcerative colitisJanuary 20, 2022Impact of intensive drug therapy on Crohn’s Disease patientsJanuary 14, 2022Coral and Crohn’s & Colitis Foundation announce partnership for inflammatory bowel diseaseJanuary 14, 20224 1234567891011 5
Enterome & Nestlé collaborate on immunotherapies for inflammatory bowel disease and food allergiesJuly 18, 2022
Coral and Crohn’s & Colitis Foundation announce partnership for inflammatory bowel diseaseJanuary 14, 2022
